论文部分内容阅读
意大利一项小规模的研究结果显示,利用自体同源的爱泼斯坦-巴尔病毒(EBV)靶向细胞毒素T淋巴细胞(CTLs)的细胞疗法可有助于控制难以治愈的鼻咽癌的恶化进程。
A small Italian study shows that cell-based therapies targeting autotrophic Epstein-Barr virus (EBV) targeting cytotoxic T lymphocytes (CTLs) can help control the worsening of refractory nasopharyngeal carcinoma process.